Vanessa Richardson
Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 3 | 2025 | 385 | 0.440 |
Why?
| | Mucociliary Clearance | 2 | 2021 | 44 | 0.320 |
Why?
| | Exercise | 3 | 2025 | 2213 | 0.270 |
Why?
| | Musculoskeletal Pain | 1 | 2026 | 48 | 0.230 |
Why?
| | Physical Therapists | 1 | 2026 | 68 | 0.220 |
Why?
| | Walking | 2 | 2025 | 546 | 0.190 |
Why?
| | Emergency Service, Hospital | 2 | 2026 | 2363 | 0.180 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2022 | 199 | 0.170 |
Why?
| | Veterans | 4 | 2026 | 1650 | 0.170 |
Why?
| | Surgical Clearance | 1 | 2021 | 5 | 0.170 |
Why?
| | Erythrocyte Transfusion | 1 | 2023 | 226 | 0.160 |
Why?
| | Disulfides | 1 | 2021 | 93 | 0.160 |
Why?
| | Cystic Fibrosis | 2 | 2021 | 1164 | 0.160 |
Why?
| | Health Services for the Aged | 1 | 2021 | 73 | 0.160 |
Why?
| | Mucus | 1 | 2021 | 75 | 0.160 |
Why?
| | Exercise Therapy | 1 | 2025 | 488 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2022 | 252 | 0.150 |
Why?
| | Patient Acceptance of Health Care | 1 | 2026 | 881 | 0.150 |
Why?
| | Physical Therapy Modalities | 1 | 2023 | 341 | 0.150 |
Why?
| | Geriatric Assessment | 1 | 2021 | 244 | 0.140 |
Why?
| | Mucin 5AC | 1 | 2018 | 71 | 0.130 |
Why?
| | Pseudomonas Infections | 1 | 2020 | 229 | 0.130 |
Why?
| | Hypersensitivity | 1 | 2021 | 253 | 0.130 |
Why?
| | Inpatients | 1 | 2021 | 540 | 0.120 |
Why?
| | Carcinogenesis | 1 | 2018 | 226 | 0.120 |
Why?
| | Lung | 4 | 2021 | 4122 | 0.110 |
Why?
| | Length of Stay | 1 | 2021 | 1358 | 0.110 |
Why?
| | Electronic Health Records | 1 | 2023 | 1210 | 0.110 |
Why?
| | Accelerometry | 2 | 2025 | 124 | 0.100 |
Why?
| | MicroRNAs | 1 | 2017 | 699 | 0.080 |
Why?
| | Sepsis | 1 | 2017 | 669 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4580 | 0.080 |
Why?
| | United States Department of Veterans Affairs | 2 | 2026 | 777 | 0.070 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 1195 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 866 | 0.070 |
Why?
| | Respiratory Function Tests | 2 | 2021 | 543 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2219 | 0.070 |
Why?
| | Male | 9 | 2026 | 73396 | 0.060 |
Why?
| | Humans | 13 | 2026 | 146342 | 0.060 |
Why?
| | Female | 9 | 2026 | 79499 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2020 | 2623 | 0.060 |
Why?
| | Telemedicine | 2 | 2025 | 966 | 0.050 |
Why?
| | Middle Aged | 5 | 2026 | 36619 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2675 | 0.050 |
Why?
| | Aged | 4 | 2025 | 26432 | 0.050 |
Why?
| | Ethics Committees, Research | 1 | 2023 | 41 | 0.050 |
Why?
| | Peroxynitrous Acid | 1 | 2022 | 11 | 0.050 |
Why?
| | Self-Management | 1 | 2024 | 207 | 0.040 |
Why?
| | Preliminary Data | 1 | 2021 | 12 | 0.040 |
Why?
| | Osteoarthritis, Knee | 1 | 2025 | 291 | 0.040 |
Why?
| | Expectorants | 1 | 2021 | 22 | 0.040 |
Why?
| | Recovery of Function | 1 | 2025 | 725 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 208 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 516 | 0.040 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2020 | 88 | 0.040 |
Why?
| | Postoperative Period | 1 | 2021 | 355 | 0.040 |
Why?
| | Health Plan Implementation | 1 | 2021 | 143 | 0.040 |
Why?
| | Estrogens | 1 | 2022 | 364 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 196 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 8123 | 0.040 |
Why?
| | Menopause | 1 | 2022 | 328 | 0.040 |
Why?
| | Veterans Health | 1 | 2020 | 188 | 0.040 |
Why?
| | Glycoproteins | 1 | 2021 | 356 | 0.040 |
Why?
| | Health Behavior | 1 | 2024 | 802 | 0.030 |
Why?
| | Sputum | 1 | 2020 | 302 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2021 | 1244 | 0.030 |
Why?
| | Patient Discharge | 1 | 2025 | 997 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2022 | 883 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 163 | 0.030 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 307 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1888 | 0.030 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 250 | 0.030 |
Why?
| | Erythrocytes | 1 | 2023 | 750 | 0.030 |
Why?
| | Program Evaluation | 1 | 2021 | 952 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1763 | 0.030 |
Why?
| | United States | 2 | 2026 | 16136 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2022 | 952 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1369 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1053 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1378 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2018 | 636 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 253 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 861 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2134 | 0.020 |
Why?
| | Animals | 3 | 2021 | 38107 | 0.020 |
Why?
| | Mice | 2 | 2021 | 18297 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1354 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1339 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 22557 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 1412 | 0.020 |
Why?
| | Child | 2 | 2021 | 22693 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3125 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2786 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4351 | 0.020 |
Why?
| | Asthma | 1 | 2021 | 1800 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 8391 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2026 | 17438 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 4093 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 6034 | 0.010 |
Why?
| | Child, Preschool | 1 | 2021 | 11913 | 0.010 |
Why?
| | Adult | 1 | 2021 | 41087 | 0.010 |
Why?
|
|
Richardson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|